Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Cell Death and Differentiation
|
April 2, 2011
Abl interconnects oncogenic Met and p53 core pathways in cancer cells
A Furlan, V Stagni, A Hussain, et al.
British Journal of Cancer
|
September 14, 2006
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
E Miranda, A Destro, A Malesci, et al.
American Heart Journal
|
January 30, 1999
Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina
F Ottani, M Galvani, D Ferrini, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 31, 2005
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations
A Destro, G L Ceresoli, M Falleni, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 12, 2004
K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers
A Destro, P Bianchi, M Alloisio, et al.
British Journal of Cancer
|
October 6, 2011
Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin
E Giovannetti, P A Zucali, Y G Assaraf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2008
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
P A Zucali, M G Ruiz, E Giovannetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2008
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
F Cappuzzo, P A Jänne, M Skokan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2007
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
F Cappuzzo, G Finocchiaro, E Rossi, et al.
British Journal of Cancer
|
June 26, 2008
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
F Cappuzzo, M Varella-Garcia, G Finocchiaro, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Cell Death and Differentiation
|
April 2, 2011
Abl interconnects oncogenic Met and p53 core pathways in cancer cells
A Furlan, V Stagni, A Hussain, et al.
British Journal of Cancer
|
September 14, 2006
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
E Miranda, A Destro, A Malesci, et al.
American Heart Journal
|
January 30, 1999
Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina
F Ottani, M Galvani, D Ferrini, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 31, 2005
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations
A Destro, G L Ceresoli, M Falleni, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 12, 2004
K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers
A Destro, P Bianchi, M Alloisio, et al.
British Journal of Cancer
|
October 6, 2011
Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin
E Giovannetti, P A Zucali, Y G Assaraf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2008
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
P A Zucali, M G Ruiz, E Giovannetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2008
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
F Cappuzzo, P A Jänne, M Skokan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2007
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
F Cappuzzo, G Finocchiaro, E Rossi, et al.
British Journal of Cancer
|
June 26, 2008
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
F Cappuzzo, M Varella-Garcia, G Finocchiaro, et al.
Page
of 2